Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03565445
Title A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | CAN

Facility Status City State Zip Country Details
Yale Center for Clinical Investigation New Haven Connecticut 06520-8028 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Cancer Center at Greater Baltimore Medical Baltimore Maryland 21153 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Oncology Hematology West P.C. dba Nebraska Cancer Specialists Omaha Nebraska 68310 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
UPMC- Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
University of South Carolina Charleston South Carolina 29425 United States Details
Sarah Cannon Research Institute - SCRI Nashville Tennessee 37203 United States Details
Henry-Joyce Cancer Center Nashville Tennessee 37232 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Virginia Cancer Care Specialist, PC Fairfax Virginia 22031 United States Details
University of Washington-Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Site CA15002 Edmonton Canada Details
Site CA15004 Montreal Canada Details
Site IT39008 Milano Italy Details
Site IT39006 Modena Italy Details
Site JP81002 Chiba Japan Details
Site JP81001 Tokyo Japan Details
Site KR82001 Seoul Korea, Republic of Details
Site KR82002 Seoul Korea, Republic of Details
Site KR82003 Seoul Korea, Republic of Details
Site KR82004 Seoul Korea, Republic of Details
Site KR82005 Seoul Korea, Republic of Details
Site KR82006 Seoul Korea, Republic of Details
Site KR82007 Seoul Korea, Republic of Details
Site PT35104 Porto Portugal Details
Site ES34002 Barcelona Spain Details
Site ES34006 Barcelona Spain Details
Site ES34010 Barcelona Spain Details
Site ES34014 Barcelona Spain Details
Site ES34003 Cataluna Spain Details
Site ES34004 Cataluna Spain Details
Site ES34007 Madrid Spain Details
Site ES34012 Madrid Spain Details
Site TW88601 Taipei Taiwan Details
Site TW88602 Taipei Taiwan Details
Site GB44006 Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field